Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 174

Similar articles for PubMed (Select 22132928)

1.

Neurocognitive effects of HIV, hepatitis C, and substance use history.

Devlin KN, Gongvatana A, Clark US, Chasman JD, Westbrook ML, Tashima KT, Navia B, Cohen RA.

J Int Neuropsychol Soc. 2012 Jan;18(1):68-78. doi: 10.1017/S1355617711001408. Epub 2011 Dec 2.

2.

Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people.

Clifford DB, Vaida F, Kao YT, Franklin DR, Letendre SL, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Grant I, Heaton RK; CHARTER Group.

Neurology. 2015 Jan 20;84(3):241-50. doi: 10.1212/WNL.0000000000001156. Epub 2014 Dec 10.

PMID:
25503616
3.

Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.

Parsons TD, Tucker KA, Hall CD, Robertson WT, Eron JJ, Fried MW, Robertson KR.

AIDS. 2006 Aug 1;20(12):1591-5.

PMID:
16868439
4.

The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease.

Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I; HNRC Group.

AIDS. 2005 Oct;19 Suppl 3:S72-8.

PMID:
16251831
5.

Neuropsychiatric impact of hepatitis C on advanced HIV.

Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P; Manhattan HIV Brain Bank.

Neurology. 2004 Mar 23;62(6):957-62.

6.

Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women.

Richardson JL, Nowicki M, Danley K, Martin EM, Cohen MH, Gonzalez R, Vassileva J, Levine AM.

AIDS. 2005 Oct 14;19(15):1659-67.

PMID:
16184036
7.

Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features.

Martin-Thormeyer EM, Paul RH.

Neuropsychol Rev. 2009 Jun;19(2):215-31. doi: 10.1007/s11065-009-9101-6. Epub 2009 May 27. Review.

8.

Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.

Clifford DB, Smurzynski M, Park LS, Yeh TM, Zhao Y, Blair L, Arens M, Evans SR.

Neurology. 2009 Jul 28;73(4):309-14. doi: 10.1212/WNL.0b013e3181af7a10.

9.

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2005 Sep 15;192(6):992-1002. Epub 2005 Aug 11.

10.

Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study.

Vassallo M, Dunais B, Durant J, Carsenti-Dellamonica H, Harvey-Langton A, Cottalorda J, Ticchioni M, Laffon M, Lebrun-Frenay C, Dellamonica P, Pradier C.

J Neurovirol. 2013 Aug;19(4):376-82. doi: 10.1007/s13365-013-0181-y. Epub 2013 Jul 12.

PMID:
23846287
11.

Neuropsychological aspects of coinfection with HIV and hepatitis C virus.

Hilsabeck RC, Castellon SA, Hinkin CH.

Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S38-44. Review.

12.

Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.

Hershow RC, O'Driscoll PT, Handelsman E, Pitt J, Hillyer G, Serchuck L, Lu M, Chen KT, Yawetz S, Pacheco S, Davenny K, Adeniyi-Jones S, Thomas DL.

Clin Infect Dis. 2005 Mar 15;40(6):859-67. Epub 2005 Feb 18.

13.

Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection.

Vigil O, Posada C, Woods SP, Atkinson JH, Heaton RK, Perry W, Hassanein TI, Grant I, Letendre SL; HIV Neurobehavioral Research Center (HNRC) Group.

J Clin Exp Neuropsychol. 2008 Oct;30(7):805-15. doi: 10.1080/13803390701802354. Epub 2008 Mar 4.

14.

Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.

Smit C, van den Berg C, Geskus R, Berkhout B, Coutinho R, Prins M.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):221-5. doi: 10.1097/QAI.0b013e31815d2f59.

PMID:
18223361
15.

Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.

Nichols SL, Bethel J, Garvie PA, Patton DE, Thornton S, Kapogiannis BG, Ren W, Major-Wilson H, Puga A, Woods SP.

J Adolesc Health. 2013 Dec;53(6):763-71. doi: 10.1016/j.jadohealth.2013.07.006. Epub 2013 Aug 21.

16.

Neurocognitive functioning in acute or early HIV infection.

Moore DJ, Letendre SL, Morris S, Umlauf A, Deutsch R, Smith DM, Little S, Rooney A, Franklin DR, Gouaux B, Leblanc S, Rosario D, Fennema-Notestine C, Heaton RK, Ellis RJ, Atkinson JH, Grant I; CHARTER Group.

J Neurovirol. 2011 Feb;17(1):50-7. doi: 10.1007/s13365-010-0009-y. Epub 2010 Dec 15.

18.

A history of alcohol dependence augments HIV-associated neurocognitive deficits in persons aged 60 and older.

Gongvatana A, Morgan EE, Iudicello JE, Letendre SL, Grant I, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

J Neurovirol. 2014 Oct;20(5):505-13. doi: 10.1007/s13365-014-0277-z. Epub 2014 Sep 9.

PMID:
25201556
19.

Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS.

Vivithanaporn P, Nelles K, DeBlock L, Newman SC, Gill MJ, Power C.

J Neurol Sci. 2012 Jan 15;312(1-2):45-51. doi: 10.1016/j.jns.2011.08.025. Epub 2011 Sep 17.

PMID:
21925684
20.

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group.

Arch Intern Med. 2002 Oct 14;162(18):2125-32.

PMID:
12374521
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk